Skip to content
MedsAcross

Medicine

Diclofenac 75 mg delayed-release tablet

Diclofenac · Oral
Available on requestPrescription onlyUS FDAGeneric name

Diclofenac 75 mg delayed-release tablet is a generic prescription medicine for oral use, made by 28 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at room temperature 20°C to 25°C (68°F to 77°F), excursions permitted…

Key facts

Active ingredient (INN)
Diclofenac
Brand
Sold under the generic name
Strength
75 mg
Dosage form
Delayed-release tablet
Route
Oral
Packs
100 tablets, 500 tablets, 60 tablets and 223 more
Manufacturers
Aurobindo PharmaIndiaUmedica LaboratoriesIndiaA-S Medication SolutionsCarlsbad TechnologyAdvagen PharmaRising Pharma HoldingsActavis PharmaSOLA Pharmaceuticals28 labelers on the register
Origin register
US FDA, United States
Storage
Store at room temperature 20°C to 25°C (68°F to 77°F), excursions permitted between 15°C and 30°C (59°F and 86°F). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
D11AX18 Diclofenac
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
26 March 1996
Identifiers
RxCUI 855664, 855906, 855926DailyMed set ID c7431496-c0ef-403a-9716-92d942709b3d, 4539e9e7-5d82-3b36-e063-6394a90a1396, 50efc183-dd3e-4eb7-ba5c-c42fd76e0b65 +37NDC 72603-604, 80425-0564, 50090-6924 +37Application ANDA216548, ANDA075185, ANDA077863 +3

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

A sample of 40 packs from 28 labelers. The register lists 226 packs for this generic presentation, and we confirm the exact pack on the quote.

PackCodeLabelerMarketed since
100 tablet, delayed release in 1 bottle59651-843-01Aurobindo PharmaIndia17 April 2025
500 tablet, delayed release in 1 bottle59651-843-05Aurobindo PharmaIndia17 April 2025
60 tablet, delayed release in 1 bottle59651-843-60Aurobindo PharmaIndia17 April 2025
1000 tablet, delayed release in 1 bottle59651-843-99Aurobindo PharmaIndia17 April 2025
60 tablet, delayed release in 1 bottle60290-084-01Umedica LaboratoriesIndia15 February 2026
100 tablet, delayed release in 1 bottle60290-084-02Umedica LaboratoriesIndia15 February 2026
500 tablet, delayed release in 1 bottle60290-084-03Umedica LaboratoriesIndia15 February 2026
1000 tablet, delayed release in 1 bottle60290-084-04Umedica LaboratoriesIndia15 February 2026
100 tablet, delayed release in 1 bottle, plastic61442-103-01Carlsbad Technology13 November 1998
500 tablet, delayed release in 1 bottle, plastic61442-103-05Carlsbad Technology13 November 1998
1000 tablet, delayed release in 1 bottle, plastic61442-103-10Carlsbad Technology13 November 1998
60 tablet, delayed release in 1 bottle, plastic61442-103-60Carlsbad Technology13 November 1998
100 tablet, delayed release in 1 bottle, plastic61442-227-01Carlsbad Technology28 March 2025
500 tablet, delayed release in 1 bottle, plastic61442-227-05Carlsbad Technology28 March 2025
1000 tablet, delayed release in 1 bottle, plastic61442-227-10Carlsbad Technology28 March 2025
60 tablet, delayed release in 1 bottle, plastic61442-227-60Carlsbad Technology28 March 2025
60 tablet, delayed release in 1 bottle0228-2551-06Actavis Pharma26 March 1996
100 tablet, delayed release in 1 bottle0228-2551-11Actavis Pharma26 March 1996
1000 tablet, delayed release in 1 bottle0228-2551-96Actavis Pharma26 March 1996
1000 tablet, delayed release in 1 bottle72888-111-00Advagen Pharma1 June 2023
100 tablet, delayed release in 1 bottle72888-111-01Advagen Pharma1 June 2023
500 tablet, delayed release in 1 bottle72888-111-05Advagen Pharma1 August 2023
30 tablet, delayed release in 1 bottle72888-111-30Advagen Pharma1 June 2023
60 tablet, delayed release in 1 bottle72888-111-60Advagen Pharma1 June 2023
60 tablet, delayed release in 1 bottle, plastic16571-201-06Rising Pharma Holdings19 August 2008
100 tablet, delayed release in 1 bottle16571-201-10Rising Pharma Holdings19 August 2008
1000 tablet, delayed release in 1 bottle16571-201-11Rising Pharma Holdings19 August 2008
500 tablet, delayed release in 1 bottle16571-201-50Rising Pharma Holdings19 August 2008
60 tablet, delayed release in 1 bottle70512-784-60SOLA Pharmaceuticals14 November 2025
100 tablet, delayed release in 1 bottle50090-0545-0A-S Medication Solutions28 November 2014
20 tablet, delayed release in 1 bottle50090-0545-1A-S Medication Solutions28 November 2014
30 tablet, delayed release in 1 bottle50090-0545-2A-S Medication Solutions28 November 2014
14 tablet, delayed release in 1 bottle50090-0545-3A-S Medication Solutions28 November 2014
60 tablet, delayed release in 1 bottle50090-0545-4A-S Medication Solutions28 November 2014
90 tablet, delayed release in 1 bottle50090-0545-8A-S Medication Solutions28 November 2014
180 tablet, delayed release in 1 bottle50090-0545-9A-S Medication Solutions28 November 2014
90 tablet, delayed release in 1 bottle50090-6924-0A-S Medication Solutions14 December 2023
100 tablet, delayed release in 1 bottle50090-7646-0A-S Medication Solutions3 September 2025
20 tablet, delayed release in 1 bottle50090-7646-1A-S Medication Solutions3 September 2025
30 tablet, delayed release in 1 bottle50090-7646-2A-S Medication Solutions3 September 2025

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 28 July 1988Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Diclofenac

Clinical summary

Diclofenac is a nonsteroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain in adult and pediatric patients 12 years of age and older. MedsAcross supplies Diclofenac for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Diclofenac

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Diclofenac 75 mg delayed-release tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.